We recently published a list of Jim Cramer’s Game Plan for This Week: 16 Stocks in Focus. In this article, we are going to ...

We recently published a list of the 10 Best Long-Term Dividend Stocks to Buy According to Billionaires. In this article, we ...

With Q4 behind us, let’s have a look at Eli Lilly (NYSE:LLY) and its peers. The branded pharmaceutical industry relies on a high-cost, high-reward business model, driven by substantial ...

Eli Lilly (LLY) is scheduled to release its Q1 earnings on May 1, and analysts continue to stay positive, holding onto Buy ...

Eli Lilly and Company’s (NYSE:LLY) Q4 2024 earnings report revealed a topline of $13.53 billion, an EPS of $5.32, and an operating income of $5.6 billion. The pharmaceutical giant continues to ...

Furthermore, hedge fund sentiment was also laid out for these stocks, as of Insider Monkey’s Q4 2024 database ... Eli Lilly and Company (NYSE:LLY), founded in 1876 and based in Indianapolis ...

Global pharmaceutical company Eli Lilly (NYSE:LLY) will be reporting results tomorrow ... some have already reported their Q4 results, giving us a hint as to what we can expect.

Viking Therapeutics, Inc.'s VK2735 has potential as a GLP-1 for obesity amid Pfizer's exit, but competition and financing risks remain. Click to know why VKTX is a Buy.

Eli Lilly's oral GLP-1 drug orforglipron showed strong Phase 3 results with 7.9% weight loss and good tolerability, ...